Inovio Pharmaceuticals (INO) P/E (2012 - 2026)
Inovio Pharmaceuticals (INO) P/E from Dec 31, 2012 to Jul 21, 2026. The TTM Inovio Pharmaceuticals (INO) P/E is -0.64. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Inovio Pharmaceuticals (INO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.64 | -27.40% |
| 2025 | -0.88 | +95.17% |
| 2024 | -0.45 | -44.30% |
| 2023 | -0.81 | -25.54% |
| 2022 | -1.09 | -68.78% |
| 2021 | -3.49 | -58.58% |
| 2020 | -8.43 | +206.93% |
| 2019 | -2.75 | -29.04% |
| 2018 | -3.87 | +9.09% |
| 2017 | -3.55 | -54.23% |
| 2016 | -7.75 | -50.11% |
| 2015 | -15.54 | +1.35% |
| 2014 | -15.33 | +75.37% |
| 2013 | -8.74 | -91.99% |
| 2012 | -109.18 | N/A |
Comparison Inovio Pharmaceuticals (INO) P/E with competitors
Inovio Pharmaceuticals (INO) P/E is -0.64.